e-Drug3D 1920 |
ERAVACYCLINE
|
cas 1207283-85-9 |
CLASS ANTIINFECTIVES |
ROUTE (list) INTRAVENOUS |
ATC code |
PK parameters VD 321 LITER |
Target TARGET 30S RIBOSOMAL SUBUNIT |
DrugCentral Unknown |
Download SDF file | 1-Pyrrolidineacetamide, N-[(5aR,6aS,7S,10aS)-9-(aminocarbonyl)-7-(dimethylamino)-4-fluoro-5,5a,6,6a,7,10,10a,12-octahydro-1,8,10a,11-tetrahydroxy-10,12-dioxo-2-naphthacenyl]- Formula: Calculated chemical properties: MW 558.56 NB_atoms 40 XLogP 0.29 PSA 182.498 NB_HD 7 NB_HA 12 fsp3 0.48 Lipinski(0=no;1=yes) 0 |
FDA NDA 211109 (pdf not found) INN (ERAVACYCLINE DIHYDROCHLORIDE) XERAVA (TETRAPHASE PHARMS) APPROVAL= AP YEAR= 2018 NEWMOLECULARENTITY |
Other links: |